Silence Says No Buyout Deal Forthcoming

While there had been optimism that Silence could successfully negotiate a buyout, recent pullbacks by the handful of big pharmas that represented the biggest technology acquirers in the RNAi space cast doubt on whether the transaction would ever occur.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.